يعرض 1 - 6 نتائج من 6 نتيجة بحث عن 'Caroline Robert (15032672)', وقت الاستعلام: 0.01s تنقيح النتائج
  1. 1
    Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

    Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 حسب Caroline Robert (15032672)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

    Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 حسب Caroline Robert (15032672)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

    Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 حسب Caroline Robert (15032672)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1

    Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1 حسب Caroline Robert (15032672)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

    Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain... حسب James S. Wilmott (15008931)

    منشور في 2025
    مؤلفون آخرون:
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases

    Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain M... حسب James S. Wilmott (15008931)

    منشور في 2025
    مؤلفون آخرون:
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: